Invention Grant
- Patent Title: Substituted heterocyclic compounds as ion channel modulators
-
Application No.: US13706879Application Date: 2012-12-06
-
Publication No.: US08664399B2Publication Date: 2014-03-04
- Inventor: Matthew Abelman , Robert H. Jiang , Jeff Zablocki
- Applicant: Gilead Sciences, Inc.
- Applicant Address: US CA Foster City
- Assignee: Gilead Sciences, Inc.
- Current Assignee: Gilead Sciences, Inc.
- Current Assignee Address: US CA Foster City
- Agent Francis O. Ginah; J. Elin Hartrum
- Main IPC: C07D413/04
- IPC: C07D413/04 ; C07D215/54 ; C07D215/14 ; C07D401/06
Abstract:
The present invention relates to sodium channel inhibitors of Formula (I): in which R1, R2, R3, R4, R5, X, Y, and Z are as defined herein, and to their use in the treatment of various disease states, including cardiovascular diseases and diabetes. The invention also relates to methods for the preparation of the compounds, and to pharmaceutical compositions containing such compounds.
Public/Granted literature
- US20130102632A1 SUBSTITUTED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS Public/Granted day:2013-04-25
Information query
